New and Generic Drug Approvals
cetirizine hydrochloride syrup, (active ingredient in Zyrtec)Taro Pharmaceutical Industries, Ltd., Approval
Durezol (difluprednate) Ophthalmic Emulsion (first ophthalmic steroid indicated for inflammation and pain ), Sirion Therapeutics, Inc., Approval
ramipril Capsules, (Altace) (for hypertension)Dr. Reddy's Labs, Ltd., Approval
Ramipril Capsules, Apotex Corp., Approval
valganciclovir hydrochloride tablets, (Valcyte) (CMV retinitis) Ranbaxy, Inc., Tentative Approval
Zaleplon capsules, (sonata) (insomnia treatment)Cipla, Ltd., Approval
Tuesday, June 24, 2008
FDA Update, 6/24/2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment